Dr. Schor of the National Institute of Neurological Disorders and Stroke has no relevant financial relationships to disclose.)
Kawasaki disease is one of the most common vasculitides in childhood. This inflammatory condition attacks the medium and small arteries with a propensity to damage the coronary arteries, thus, making it the most common cause of acquired heart disease in childhood. Treatment with intravenous immunoglobulin is effective at preventing damage to coronary arteries. In this article, the authors review the symptoms, signs, and pathophysiology of Kawasaki disease. The latest treatment recommendations are also reviewed.
Historical note and terminology
Kawasaki disease is a vasculitis of the medium and small arteries with a propensity to damage the coronary arteries. Dr. Tomisaku Kawasaki first reported 7 cases of “Non-scarlet fever desquamation syndrome” in 1962 followed by “20 cases of ocular-mucocutaneous syndrome” in 1964. His classic report was published in 1967 and included a description of 50 children with what he described as “pediatric acute febrile mucocutaneous lymph node syndrome with characteristic desquamation of the fingers and toes” (Kawasaki 1967). In this paper, Dr. Kawasaki described the cardinal characteristics that have since come to classify the illness. In 1975, Kato and colleagues published the first large case series describing the coronary artery abnormalities associated with Kawasaki disease (Kato et al 1975). The first published case series describing “mucocutaneous lymph node syndrome” in the United States was reported in 1976 (Melish et al 1976). The connection between Kawasaki disease and ensuing coronary artery aneurysm has proven significant. Kawasaki disease has replaced acute rheumatic fever as the most common cause of acquired heart disease in industrialized countries.
The content you are trying to view is available only to logged in, current MedLink Neurology subscribers.
If you are a subscriber, please log in.
If you are a former subscriber or have registered before, please log in first and then click select a Service Plan or contact Subscriber Services. Site license users, click the Site License Acces link on the Homepage at an authorized computer.